• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » 3M counters sabotage charge with blackmail lawsuit

3M counters sabotage charge with blackmail lawsuit

June 22, 2011 By MedCity News

3M Co. (NYSE:MMM) came out swinging against two U.K. firms that launched a lawsuit against the St. Paul, Minn. company for allegedly sabotaging a technology it acquired from that firm.

In a counter lawsuit the diversified conglomerate filed in a state court in New York, 3M said that Porton Group and its CEO Harvey Boulter have launched a campaign of "blackmail" and "extortion" to get a $30 million payment, Bloomberg reports.

The legal back-and-forth has its roots in a 2007 transaction. That’s when 3M bought a potential breakthrough device from Acolyte, a U.K. company owned by the Porton Group and Ploughshare Innovations, a subsidiary of the U.K. Ministry of Defence. The device, called BacLite, used a special fluorescent light to detect the antibiotic-resistant superbug known as MRSA.

MedCity News logo

The Porton Group achieved 95 percent success in detecting MRSA in European clinical trials, but when 3M performed the trials, they were only 50 percent effective. The attorneys for the Porton Group alleged in mid-May that 3M botched the trial by keeping the bacteria below body temperature. They added that the reason 3M sabotaged the trial was because it was developing a more expensive molecular test to detect MRSA internally, called the Simplexa, and wanted it to be the first to reach the market.

Now, the Porton Group and Ploughshare Innovations are seeking $67 million in damages from 3M in a lawsuit that began last week in the U.K.

3M said that the BacLite technology was not commercially viable, which led the company to abandon efforts to sell it in 2008.

In its lawsuit against Porton and Boulter, 3M alleged the following in the complaint, according to Bloomberg:

"Instead of awaiting the outcome of the pending litigation, defendants and their investors have engaged in an unlawful campaign to blackmail 3M into paying $30 million in order to avoid the continuation of the campaign."

The complaint added that "defendants seek to publicly defame 3M and its chairman/CEO," Bloomberg reported.

Filed Under: Legal News, News Well Tagged With: 3m, Ploughshare Innovations, Porton Group

More recent news

  • Autonomix picks up key nerve ablation catheter patent
  • Affluent Medical can move to pivotal phase of artificial urinary sphincter study
  • Globus Medical announces $500M share repurchase program
  • Cook Medical warns of issue with angiographic catheter
  • Virtuoso Surgical reports first cases with robotic endoscopy system, plans FDA IDE submission

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy